ARCHIVES

Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

White House Picks Harold Varmus For NCI

May 21, 2010

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Kennedy Agrees To Drop Dollar Limit In New Cancer Bill

January 11, 1980

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012